Maze Therapeutics, Inc. Common Stock (MAZE) — Defensive Interval Ratio
Maze Therapeutics, Inc. Common Stock (MAZE) has a Defensive Interval Ratio of 2495 days as of December 2025. Defensive assets of $154.17 Million (cash $-, short-term investments $152.67 Million, receivables $1.50 Million) cover 2495 days of daily cash needs of $61.80K/day. Check MAZE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Maze Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Maze Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 2495 days, meaning defensive assets of $154.17 Million can fund 2495 days of operations without new revenue. Also explore net asset growth rate of Maze Therapeutics, Inc. Common Stock to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Maze Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Maze Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Maze Therapeutics, Inc. Common Stock (MAZE) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2495 days | $154.17 Million | $61.80K/day | $- | $152.67 Million | ▲ +2495 days |
| 2024 | 0 days | $0.00 | $56.64K/day | $- | $0.00 | — |